Management of Asymptomatic Patients with Moderate Coronary Artery Stenosis

Risk Assessment and Classification

The European Society of Cardiology recommends that an Agatston calcium score of 174 indicates moderate coronary artery calcification and places a patient at elevated cardiovascular risk despite being asymptomatic 1, 2
The American College of Cardiology states that moderate (40-50%) stenosis of the LAD artery represents significant coronary artery disease that requires intervention, even in asymptomatic individuals 1, 3
The combination of multiple risk factors (hypertension, hyperlipidemia, family history) further increases a patient's risk profile, according to the American College of Cardiology 3, 4

The American College of Cardiology strongly recommends high-intensity statin therapy as first-line treatment to achieve ≥50% reduction in LDL-C from baseline and an LDL-C goal of <1.4 mmol/L (<55 mg/dL) 3, 2
The American Heart Association recommends that beta-blockers should be initiated as part of the treatment regimen for coronary artery disease, particularly for controlling heart rate and reducing myocardial oxygen demand 4, 2
The American College of Cardiology recommends that an ACE inhibitor (or ARB if not tolerated) is due to the presence of hypertension and coronary artery disease 5, 4
The American College of Cardiology recommends low-dose aspirin (75-100 mg daily) for primary prevention in high-risk patients 4, 2

The European Society of Cardiology recommends a comprehensive lifestyle modification program, including a heart-healthy diet (Mediterranean, DASH, or AHA diet) with reduced saturated fat (<7% of total calories) and sodium intake 4, 2
The American Heart Association recommends regular aerobic physical activity of at least 150-300 minutes per week of moderate intensity 1, 2

The American Heart Association recommends that blood pressure should be controlled to <130/80 mmHg given the presence of coronary artery disease 5, 4
The American College of Cardiology recommends that LDL-C target should be <1.4 mmol/L (<55 mg/dL) due to the documented coronary artery disease 3, 2

The American College of Cardiology recommends regular follow-up visits every 3-6 months initially to monitor symptoms, medication adherence, and risk factor control 2
The American College of Cardiology recommends that lipid profile should be assessed 4-12 weeks after initiating statin therapy to evaluate response 3
The European Society of Cardiology recommends consideration of non-invasive functional imaging for myocardial ischemia (stress test) to evaluate for inducible ischemia, particularly if symptoms develop 1